| 0 |
ANTACID THERAPY |
23 |
0.1769 |
| 1 |
APPENDICOLITH |
58 |
0.1499 |
| 2 |
SLEEP DISORDER THERAPY |
29 |
0.1465 |
| 3 |
ANALGESIC THERAPY |
33 |
0.1028 |
| 4 |
DRUG THERAPY |
32 |
0.0944 |
| 5 |
CONGENITAL HIATUS HERNIA |
21 |
0.0921 |
| 6 |
MALIGNANT MELANOMA STAGE 0 |
17 |
0.0813 |
| 7 |
CARBUNCLE |
23 |
0.0813 |
| 8 |
ANTICOAGULANT THERAPY |
23 |
0.0810 |
| 9 |
BACTEROIDES INFECTION |
18 |
0.0690 |
| 10 |
PHRENIC NERVE INJURY |
1 |
0.0500 |
| 11 |
NEUROLOGICAL COMPLICATION ASSOCIATED WITH DEVICE |
1 |
0.0323 |
| 12 |
MONOCLONAL IMMUNOGLOBULIN PRESENT |
23 |
0.0303 |
| 13 |
BENIGN OESOPHAGEAL NEOPLASM |
1 |
0.0286 |
| 14 |
DISLOCATION OF VERTEBRA |
62 |
0.0272 |
| 15 |
ADJUSTMENT DISORDER WITH DEPRESSED MOOD |
54 |
0.0260 |
| 16 |
WRIST DEFORMITY |
15 |
0.0244 |
| 17 |
CYP2D6 POLYMORPHISM |
1 |
0.0227 |
| 18 |
HYPERPHOSPHATAEMIA |
48 |
0.0223 |
| 19 |
PROGESTERONE ABNORMAL |
1 |
0.0222 |
| 20 |
RED BLOOD CELL BURR CELLS PRESENT |
1 |
0.0222 |
| 21 |
BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC |
19 |
0.0205 |
| 22 |
BLOOD PHOSPHORUS INCREASED |
54 |
0.0198 |
| 23 |
SUBCUTANEOUS DRUG ABSORPTION IMPAIRED |
9 |
0.0160 |
| 24 |
HYPOTHALAMO-PITUITARY DISORDER |
23 |
0.0158 |
| 25 |
TOTAL LUNG CAPACITY DECREASED |
24 |
0.0150 |
| 26 |
CEREBRAL VENTRICLE COLLAPSE |
1 |
0.0133 |
| 27 |
MEAN PLATELET VOLUME ABNORMAL |
1 |
0.0125 |
| 28 |
RHEUMATOID FACTOR POSITIVE |
67 |
0.0116 |
| 29 |
C-REACTIVE PROTEIN ABNORMAL |
68 |
0.0106 |
| 30 |
ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE |
65 |
0.0091 |
| 31 |
BLOOD URIC ACID INCREASED |
52 |
0.0090 |
| 32 |
GRIP STRENGTH |
2 |
0.0087 |
| 33 |
FACET JOINT SYNDROME |
28 |
0.0086 |
| 34 |
LIVER FUNCTION TEST |
1 |
0.0085 |
| 35 |
IRON DEFICIENCY |
38 |
0.0084 |
| 36 |
SWOLLEN JOINT COUNT |
2 |
0.0080 |
| 37 |
LUNG OPACITY |
21 |
0.0080 |
| 38 |
LIP DRY |
68 |
0.0075 |
| 39 |
FIBROSIS |
23 |
0.0075 |
| 40 |
AORTIC STENOSIS |
26 |
0.0075 |
| 41 |
MYASTHENIA GRAVIS |
60 |
0.0074 |
| 42 |
CRYPTITIS |
1 |
0.0072 |
| 43 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
36 |
0.0071 |
| 44 |
PERIPHERAL VENOUS DISEASE |
29 |
0.0071 |
| 45 |
HYPOPHOSPHATAEMIA |
52 |
0.0070 |
| 46 |
APPENDICITIS |
59 |
0.0063 |
| 47 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
106 |
0.0062 |
| 48 |
SERONEGATIVE ARTHRITIS |
7 |
0.0061 |
| 49 |
MANIC SYMPTOM |
1 |
0.0060 |
| 50 |
MULTIFOCAL MOTOR NEUROPATHY |
1 |
0.0057 |
| 51 |
BONE EROSION |
20 |
0.0056 |
| 52 |
LUPUS VULGARIS |
7 |
0.0056 |
| 53 |
PLEURITIC PAIN |
15 |
0.0054 |
| 54 |
HAND DEFORMITY |
71 |
0.0054 |
| 55 |
HELICOBACTER INFECTION |
55 |
0.0053 |
| 56 |
VENTRICULAR FIBRILLATION |
59 |
0.0053 |
| 57 |
RESPIRATORY SYMPTOM |
15 |
0.0053 |
| 58 |
JOINT RANGE OF MOTION DECREASED |
70 |
0.0052 |
| 59 |
PEMPHIGUS |
65 |
0.0052 |
| 60 |
BREAST CANCER STAGE II |
43 |
0.0052 |
| 61 |
FINGER DEFORMITY |
25 |
0.0052 |
| 62 |
DEAFNESS PERMANENT |
1 |
0.0051 |
| 63 |
X-RAY ABNORMAL |
9 |
0.0050 |
| 64 |
ILIUM FRACTURE |
1 |
0.0049 |
| 65 |
SYNOVITIS |
87 |
0.0048 |
| 66 |
MERALGIA PARAESTHETICA |
1 |
0.0047 |
| 67 |
SWOLLEN JOINT COUNT INCREASED |
15 |
0.0047 |
| 68 |
DYSLIPIDAEMIA |
23 |
0.0045 |
| 69 |
DEEP VEIN THROMBOSIS POSTOPERATIVE |
9 |
0.0045 |
| 70 |
OVERWEIGHT |
23 |
0.0043 |
| 71 |
INJECTION SITE NERVE DAMAGE |
1 |
0.0042 |
| 72 |
ASPARTATE AMINOTRANSFERASE |
1 |
0.0041 |
| 73 |
TROPONIN INCREASED |
30 |
0.0039 |
| 74 |
CARDIOGENIC SHOCK |
55 |
0.0038 |
| 75 |
DUODENAL ULCER PERFORATION |
28 |
0.0038 |
| 76 |
HEART FAILURE WITH REDUCED EJECTION FRACTION |
2 |
0.0037 |
| 77 |
MUSCLE INJURY |
31 |
0.0037 |
| 78 |
IMMATURE GRANULOCYTE COUNT INCREASED |
1 |
0.0035 |
| 79 |
JEALOUS DELUSION |
1 |
0.0035 |
| 80 |
BENIGN PROSTATIC HYPERPLASIA |
18 |
0.0035 |
| 81 |
BLOOD CALCIUM INCREASED |
30 |
0.0034 |
| 82 |
BREAST CANCER STAGE III |
22 |
0.0034 |
| 83 |
RHEUMATIC FEVER |
15 |
0.0034 |
| 84 |
POLYCHROMASIA |
1 |
0.0033 |
| 85 |
BUTTOCK INJURY |
1 |
0.0033 |
| 86 |
GLOSSODYNIA |
72 |
0.0032 |
| 87 |
SKIN OPERATION |
1 |
0.0032 |
| 88 |
BREATH SOUNDS ABNORMAL |
15 |
0.0030 |
| 89 |
PULMONARY FIBROSIS |
57 |
0.0030 |
| 90 |
PSEUDOSTROKE |
1 |
0.0029 |
| 91 |
RENAL CYST |
23 |
0.0029 |
| 92 |
RETINITIS |
5 |
0.0029 |
| 93 |
LIGAMENT OPERATION |
1 |
0.0029 |
| 94 |
BACK DISORDER |
47 |
0.0029 |
| 95 |
TENOPLASTY |
1 |
0.0029 |
| 96 |
ANION GAP DECREASED |
1 |
0.0029 |
| 97 |
OVERLAP SYNDROME |
2 |
0.0029 |
| 98 |
PRESCRIBED OVERDOSE |
55 |
0.0028 |
| 99 |
HYPOCHOLESTEROLAEMIA |
1 |
0.0028 |
| 100 |
BURNING SENSATION MUCOSAL |
1 |
0.0028 |
| 101 |
FOLLICULITIS |
29 |
0.0028 |
| 102 |
BACTERIAL INFECTION |
49 |
0.0026 |
| 103 |
PUSTULAR PSORIASIS |
9 |
0.0026 |
| 104 |
PURPURA |
23 |
0.0026 |
| 105 |
OESOPHAGEAL INJURY |
1 |
0.0026 |
| 106 |
URINARY CASTS |
1 |
0.0026 |
| 107 |
PRESCRIBED UNDERDOSE |
51 |
0.0026 |
| 108 |
CONVULSIVE THRESHOLD LOWERED |
1 |
0.0025 |
| 109 |
HYPERCHOLESTEROLAEMIA |
24 |
0.0025 |
| 110 |
NEPHROPATHY |
23 |
0.0025 |
| 111 |
HYPERLIPIDAEMIA |
29 |
0.0024 |
| 112 |
LOWER LIMB FRACTURE |
45 |
0.0023 |
| 113 |
BURSITIS |
28 |
0.0023 |
| 114 |
EYELID INFECTION |
1 |
0.0023 |
| 115 |
WOUND |
63 |
0.0023 |
| 116 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
62 |
0.0022 |
| 117 |
BODY HEIGHT DECREASED |
23 |
0.0021 |
| 118 |
NEURALGIA |
52 |
0.0021 |
| 119 |
ULCER |
34 |
0.0021 |
| 120 |
BLOOD TEST ABNORMAL |
30 |
0.0021 |
| 121 |
BLOOD PHOSPHORUS ABNORMAL |
1 |
0.0021 |
| 122 |
LOWER RESPIRATORY TRACT INFECTION |
96 |
0.0021 |
| 123 |
SHOCK HYPOGLYCAEMIC |
1 |
0.0021 |
| 124 |
ASCITES |
58 |
0.0020 |
| 125 |
STOMA COMPLICATION |
2 |
0.0020 |
| 126 |
JOINT DESTRUCTION |
3 |
0.0019 |
| 127 |
GOUT |
34 |
0.0019 |
| 128 |
SCIATICA |
30 |
0.0019 |
| 129 |
RASH VESICULAR |
9 |
0.0019 |
| 130 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
66 |
0.0019 |
| 131 |
ASPIRATION |
20 |
0.0018 |
| 132 |
OBESITY |
29 |
0.0018 |
| 133 |
FIBROMYALGIA |
44 |
0.0018 |
| 134 |
END STAGE RENAL DISEASE |
33 |
0.0018 |
| 135 |
FOOT DEFORMITY |
20 |
0.0018 |
| 136 |
REPETITIVE SPEECH |
1 |
0.0018 |
| 137 |
RENAL TUBULAR DYSFUNCTION |
1 |
0.0018 |
| 138 |
GAIT INABILITY |
59 |
0.0018 |
| 139 |
BLOOD CHOLESTEROL INCREASED |
80 |
0.0017 |
| 140 |
LIVER INJURY |
42 |
0.0017 |
| 141 |
GRIP STRENGTH DECREASED |
15 |
0.0017 |
| 142 |
LIVER DISORDER |
75 |
0.0017 |
| 143 |
DIAPHRAGMATIC PARALYSIS |
1 |
0.0017 |
| 144 |
PERICARDITIS |
28 |
0.0017 |
| 145 |
SACRAL PAIN |
1 |
0.0016 |
| 146 |
NEURODEGENERATIVE DISORDER |
1 |
0.0016 |
| 147 |
DELIRIUM |
56 |
0.0016 |
| 148 |
EXCESSIVE CERUMEN PRODUCTION |
1 |
0.0016 |
| 149 |
FULL BLOOD COUNT ABNORMAL |
17 |
0.0016 |
| 150 |
ANAL INFLAMMATION |
1 |
0.0016 |
| 151 |
ARTHROPATHY |
87 |
0.0016 |
| 152 |
MUSCULOSKELETAL PAIN |
82 |
0.0016 |
| 153 |
ACTIVITIES OF DAILY LIVING DECREASED |
1 |
0.0016 |
| 154 |
CELLULITIS STAPHYLOCOCCAL |
1 |
0.0015 |
| 155 |
PERSONAL RELATIONSHIP ISSUE |
1 |
0.0015 |
| 156 |
MICTURITION URGENCY |
17 |
0.0015 |
| 157 |
SPINAL FUSION SURGERY |
6 |
0.0015 |
| 158 |
ECHOCARDIOGRAM ABNORMAL |
2 |
0.0014 |
| 159 |
DRUG TOLERANCE DECREASED |
4 |
0.0014 |
| 160 |
HEPATIC ENZYME INCREASED |
97 |
0.0014 |
| 161 |
PORPHYRIA ACUTE |
2 |
0.0014 |
| 162 |
PARASOMNIA |
1 |
0.0014 |
| 163 |
SUSPECTED OFF LABEL USE |
6 |
0.0013 |
| 164 |
OSTEOARTHRITIS |
56 |
0.0013 |
| 165 |
PSORIATIC ARTHROPATHY |
53 |
0.0013 |
| 166 |
DEBRIDEMENT |
1 |
0.0013 |
| 167 |
MYASTHENIC SYNDROME |
1 |
0.0013 |
| 168 |
OEDEMA |
69 |
0.0013 |
| 169 |
IRRITABLE BOWEL SYNDROME |
27 |
0.0013 |
| 170 |
GOUTY ARTHRITIS |
1 |
0.0013 |
| 171 |
DISCOMFORT |
76 |
0.0012 |
| 172 |
HAPTOGLOBIN DECREASED |
1 |
0.0012 |
| 173 |
HEPATIC STEATOSIS |
23 |
0.0012 |
| 174 |
WALKING AID USER |
8 |
0.0012 |
| 175 |
LIVER FUNCTION TEST INCREASED |
26 |
0.0012 |
| 176 |
EPILEPSY |
37 |
0.0012 |
| 177 |
RALES |
7 |
0.0012 |
| 178 |
GENERAL SYMPTOM |
9 |
0.0012 |
| 179 |
FLUID RETENTION |
61 |
0.0012 |
| 180 |
LUNG OPERATION |
1 |
0.0012 |
| 181 |
MEAN PLATELET VOLUME DECREASED |
1 |
0.0012 |
| 182 |
SOLILOQUY |
1 |
0.0012 |
| 183 |
HYPONATRAEMIA |
65 |
0.0012 |
| 184 |
NAIL DISORDER |
10 |
0.0011 |
| 185 |
BLEPHAROSPASM |
7 |
0.0011 |
| 186 |
JOINT STIFFNESS |
29 |
0.0011 |
| 187 |
WOUND INFECTION |
12 |
0.0011 |
| 188 |
TRAUMATIC INTRACRANIAL HAEMORRHAGE |
1 |
0.0011 |
| 189 |
PREMATURE MENOPAUSE |
1 |
0.0011 |
| 190 |
LUNG DISORDER |
53 |
0.0011 |
| 191 |
C-REACTIVE PROTEIN |
1 |
0.0011 |
| 192 |
CATHETER SITE SWELLING |
1 |
0.0011 |
| 193 |
GENERAL PHYSICAL HEALTH DETERIORATION |
123 |
0.0011 |
| 194 |
INJURY |
74 |
0.0011 |
| 195 |
ROAD TRAFFIC ACCIDENT |
44 |
0.0011 |
| 196 |
WRONG SCHEDULE |
1 |
0.0010 |
| 197 |
PARTNER STRESS |
1 |
0.0010 |
| 198 |
RED BLOOD CELL ABNORMALITY |
1 |
0.0010 |
| 199 |
BRONCHIECTASIS |
7 |
0.0010 |
| 200 |
DRY MOUTH |
84 |
0.0010 |
| 201 |
DRUG INTOLERANCE |
100 |
0.0010 |
| 202 |
ANIMAL SCRATCH |
1 |
0.0010 |
| 203 |
INFUSION SITE REACTION |
3 |
0.0010 |
| 204 |
MYOSITIS |
9 |
0.0010 |
| 205 |
INFUSION RELATED REACTION |
66 |
0.0010 |
| 206 |
MUSCULOSKELETAL STIFFNESS |
87 |
0.0010 |
| 207 |
DIABETES MELLITUS |
75 |
0.0010 |
| 208 |
IRON DEFICIENCY ANAEMIA |
9 |
0.0010 |
| 209 |
CHANGE OF BOWEL HABIT |
2 |
0.0010 |
| 210 |
SLEEP DISORDER |
68 |
0.0010 |
| 211 |
SLEEP DEFICIT |
2 |
0.0009 |
| 212 |
PANCREATIC MASS |
1 |
0.0009 |
| 213 |
NIGHT SWEATS |
30 |
0.0009 |
| 214 |
SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE |
6 |
0.0009 |
| 215 |
STAPHYLOCOCCAL BACTERAEMIA |
4 |
0.0009 |
| 216 |
POST PROCEDURAL SWELLING |
1 |
0.0009 |
| 217 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
47 |
0.0009 |
| 218 |
SWELLING |
84 |
0.0009 |
| 219 |
LIMB INJURY |
24 |
0.0009 |
| 220 |
EXOSTOSIS |
8 |
0.0009 |
| 221 |
PROCALCITONIN INCREASED |
1 |
0.0009 |
| 222 |
SENSE OF OPPRESSION |
1 |
0.0008 |
| 223 |
AMNESIA |
55 |
0.0008 |
| 224 |
REFLUX GASTRITIS |
1 |
0.0008 |
| 225 |
BLEEDING TIME PROLONGED |
1 |
0.0008 |
| 226 |
SPONDYLITIS |
3 |
0.0008 |
| 227 |
IMPAIRED HEALING |
27 |
0.0008 |
| 228 |
AUTOIMMUNE DISORDER |
8 |
0.0008 |
| 229 |
EJECTION FRACTION ABNORMAL |
1 |
0.0008 |
| 230 |
INFUSION SITE WARMTH |
1 |
0.0008 |
| 231 |
MOVEMENT DISORDER |
26 |
0.0008 |
| 232 |
HYPERVOLAEMIA |
4 |
0.0008 |
| 233 |
MALIGNANT MELANOMA IN SITU |
1 |
0.0008 |
| 234 |
INTRA-ABDOMINAL HAEMATOMA |
1 |
0.0008 |
| 235 |
JOINT INJURY |
17 |
0.0008 |
| 236 |
DYSSTASIA |
23 |
0.0008 |
| 237 |
STOMA SITE INFECTION |
1 |
0.0008 |
| 238 |
COUNTERFEIT PRODUCT ADMINISTERED |
1 |
0.0008 |
| 239 |
TRANSAMINASES INCREASED |
17 |
0.0008 |
| 240 |
OSTEOPOROSIS |
31 |
0.0008 |
| 241 |
POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME |
1 |
0.0007 |
| 242 |
ULCER HAEMORRHAGE |
5 |
0.0007 |
| 243 |
SPUTUM DISCOLOURED |
7 |
0.0007 |
| 244 |
BONE DENSITY DECREASED |
23 |
0.0007 |
| 245 |
STOMA SITE DISCHARGE |
2 |
0.0007 |
| 246 |
DISCHARGE |
1 |
0.0007 |
| 247 |
ONYCHOMADESIS |
3 |
0.0007 |
| 248 |
CHOLELITHIASIS |
23 |
0.0007 |
| 249 |
SKIN DISORDER |
23 |
0.0007 |
| 250 |
THROMBOSIS |
54 |
0.0007 |
| 251 |
INJECTION SITE PARAESTHESIA |
1 |
0.0007 |
| 252 |
ABDOMINAL DISTENSION |
67 |
0.0006 |
| 253 |
TASTE DISORDER |
13 |
0.0006 |
| 254 |
URINE KETONE BODY PRESENT |
1 |
0.0006 |
| 255 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED |
7 |
0.0006 |
| 256 |
OBSTRUCTIVE AIRWAYS DISORDER |
7 |
0.0006 |
| 257 |
ILLUSION |
1 |
0.0006 |
| 258 |
MEAN CELL HAEMOGLOBIN INCREASED |
1 |
0.0006 |
| 259 |
DYSPEPSIA |
59 |
0.0006 |
| 260 |
CARDIOVASCULAR DISORDER |
15 |
0.0006 |
| 261 |
INTENTIONAL PRODUCT MISUSE |
51 |
0.0006 |
| 262 |
RHEUMATOID ARTHRITIS |
66 |
0.0006 |
| 263 |
BLOOD CHLORIDE INCREASED |
1 |
0.0006 |
| 264 |
SEPSIS |
64 |
0.0006 |
| 265 |
POLYARTHRITIS |
3 |
0.0006 |
| 266 |
UPPER RESPIRATORY TRACT INFECTION |
26 |
0.0006 |
| 267 |
CORONARY ARTERY DISEASE |
17 |
0.0006 |
| 268 |
DISABILITY |
11 |
0.0006 |
| 269 |
NORMAL NEWBORN |
3 |
0.0006 |
| 270 |
LUPUS-LIKE SYNDROME |
5 |
0.0006 |
| 271 |
CONTUSION |
53 |
0.0005 |
| 272 |
SCLERODERMA |
2 |
0.0005 |
| 273 |
PULMONARY EMBOLISM |
52 |
0.0005 |
| 274 |
STOMATITIS |
33 |
0.0005 |
| 275 |
WHEEZING |
32 |
0.0005 |
| 276 |
JOINT SWELLING |
65 |
0.0005 |
| 277 |
PULMONARY MASS |
8 |
0.0005 |
| 278 |
STOMA SITE ERYTHEMA |
1 |
0.0005 |
| 279 |
TRANSIENT ISCHAEMIC ATTACK |
18 |
0.0005 |
| 280 |
MATERNAL EXPOSURE TIMING UNSPECIFIED |
2 |
0.0005 |
| 281 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
9 |
0.0005 |
| 282 |
HIP ARTHROPLASTY |
8 |
0.0005 |
| 283 |
PATIENT DISSATISFACTION WITH TREATMENT |
1 |
0.0005 |
| 284 |
OEDEMA PERIPHERAL |
63 |
0.0005 |
| 285 |
BICYTOPENIA |
1 |
0.0005 |
| 286 |
RENAL HAEMORRHAGE |
1 |
0.0005 |
| 287 |
BLOOD CREATININE INCREASED |
32 |
0.0005 |
| 288 |
PSYCHOTIC SYMPTOM |
1 |
0.0005 |
| 289 |
INFLAMMATION |
25 |
0.0005 |
| 290 |
LIVE BIRTH |
4 |
0.0005 |
| 291 |
JOINT DISLOCATION |
5 |
0.0005 |
| 292 |
CATHETER SITE ERYTHEMA |
1 |
0.0005 |
| 293 |
HAEMOPTYSIS |
13 |
0.0005 |
| 294 |
CONTRAINDICATED PRODUCT ADMINISTERED |
14 |
0.0005 |
| 295 |
VITREOUS DETACHMENT |
1 |
0.0005 |
| 296 |
BACK INJURY |
5 |
0.0005 |
| 297 |
ONYCHOMYCOSIS |
2 |
0.0005 |
| 298 |
TEMPERATURE REGULATION DISORDER |
1 |
0.0004 |
| 299 |
BLISTER |
25 |
0.0004 |
| 300 |
CONDITION AGGRAVATED |
135 |
0.0004 |
| 301 |
PLEURAL EFFUSION |
27 |
0.0004 |
| 302 |
ACUTE HEPATIC FAILURE |
6 |
0.0004 |
| 303 |
CHEST PAIN |
80 |
0.0004 |
| 304 |
YELLOW SKIN |
2 |
0.0004 |
| 305 |
HEPATIC CIRRHOSIS |
8 |
0.0004 |
| 306 |
LEARNING DISORDER |
1 |
0.0004 |
| 307 |
BLOOD IMMUNOGLOBULIN E INCREASED |
1 |
0.0004 |
| 308 |
BLOOD PRESSURE SYSTOLIC ABNORMAL |
1 |
0.0004 |
| 309 |
PERSECUTORY DELUSION |
1 |
0.0004 |
| 310 |
LABYRINTHITIS |
1 |
0.0004 |
| 311 |
INFECTION |
57 |
0.0004 |
| 312 |
KNEE ARTHROPLASTY |
8 |
0.0004 |
| 313 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
1 |
0.0004 |
| 314 |
ANIMAL BITE |
1 |
0.0004 |
| 315 |
ABDOMINAL MASS |
1 |
0.0004 |
| 316 |
ABDOMINAL PAIN |
86 |
0.0004 |
| 317 |
ARTHRITIS |
29 |
0.0004 |
| 318 |
MIGRAINE WITH AURA |
1 |
0.0004 |
| 319 |
PROCTITIS |
1 |
0.0004 |
| 320 |
ALOPECIA |
70 |
0.0004 |
| 321 |
TYPE 2 DIABETES MELLITUS |
12 |
0.0004 |
| 322 |
HYPERTENSION |
75 |
0.0004 |
| 323 |
PRODUCT LABEL CONFUSION |
2 |
0.0003 |
| 324 |
SOMNOLENCE |
69 |
0.0003 |
| 325 |
AUTONOMIC NERVOUS SYSTEM IMBALANCE |
1 |
0.0003 |
| 326 |
NECK INJURY |
1 |
0.0003 |
| 327 |
REBOUND ACID HYPERSECRETION |
1 |
0.0003 |
| 328 |
EYE INJURY |
1 |
0.0003 |
| 329 |
INFUSION SITE PRURITUS |
1 |
0.0003 |
| 330 |
ELECTROENCEPHALOGRAM ABNORMAL |
1 |
0.0003 |
| 331 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
8 |
0.0003 |
| 332 |
LISTLESS |
1 |
0.0003 |
| 333 |
NEAR DEATH EXPERIENCE |
1 |
0.0003 |
| 334 |
PSORIASIS |
38 |
0.0003 |
| 335 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
13 |
0.0003 |
| 336 |
GASTROINTESTINAL DISORDER |
26 |
0.0003 |
| 337 |
CERVICAL VERTEBRAL FRACTURE |
1 |
0.0003 |
| 338 |
HYPOPNOEA |
1 |
0.0003 |
| 339 |
DRUG-INDUCED LIVER INJURY |
9 |
0.0003 |
| 340 |
DEPRESSIVE SYMPTOM |
1 |
0.0003 |
| 341 |
ANAEMIA |
54 |
0.0003 |
| 342 |
ASPARTATE AMINOTRANSFERASE INCREASED |
15 |
0.0003 |
| 343 |
HAEMORRHAGIC DIATHESIS |
1 |
0.0003 |
| 344 |
CONSTIPATION |
61 |
0.0003 |
| 345 |
HYPOAESTHESIA |
41 |
0.0003 |
| 346 |
PRODUCT USE ISSUE |
51 |
0.0003 |
| 347 |
BLOOD PRESSURE DIASTOLIC DECREASED |
2 |
0.0003 |
| 348 |
CONJUNCTIVAL HAEMORRHAGE |
1 |
0.0003 |
| 349 |
THYROID MASS |
1 |
0.0003 |
| 350 |
THERAPEUTIC PRODUCT EFFECT VARIABLE |
1 |
0.0003 |
| 351 |
RHINOVIRUS INFECTION |
1 |
0.0003 |
| 352 |
BRAIN FOG |
4 |
0.0003 |
| 353 |
PROSTATOMEGALY |
1 |
0.0003 |
| 354 |
NAIL DISCOLOURATION |
1 |
0.0003 |
| 355 |
C-REACTIVE PROTEIN INCREASED |
9 |
0.0002 |
| 356 |
ADRENAL INSUFFICIENCY |
3 |
0.0002 |
| 357 |
PERIPHERAL SWELLING |
38 |
0.0002 |
| 358 |
SPINAL STENOSIS |
1 |
0.0002 |
| 359 |
ASTHMA |
27 |
0.0002 |
| 360 |
ARTHRALGIA |
99 |
0.0002 |
| 361 |
DECREASED APPETITE |
55 |
0.0002 |
| 362 |
MUSCLE STRAIN |
2 |
0.0002 |
| 363 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
11 |
0.0002 |
| 364 |
GROIN PAIN |
2 |
0.0002 |
| 365 |
HYPOXIA |
8 |
0.0002 |
| 366 |
PHYSICAL DISABILITY |
1 |
0.0002 |
| 367 |
BLOOD CREATINE INCREASED |
1 |
0.0002 |
| 368 |
EAR INFECTION |
6 |
0.0002 |
| 369 |
GAIT DISTURBANCE |
43 |
0.0002 |
| 370 |
GASTROINTESTINAL INFECTION |
2 |
0.0002 |
| 371 |
MENINGITIS ASEPTIC |
1 |
0.0002 |
| 372 |
MOBILITY DECREASED |
16 |
0.0002 |
| 373 |
RENAL FAILURE |
29 |
0.0002 |
| 374 |
PNEUMONIA BACTERIAL |
2 |
0.0002 |
| 375 |
BRAIN NEOPLASM |
2 |
0.0002 |
| 376 |
BLOOD PRESSURE DIASTOLIC INCREASED |
1 |
0.0002 |
| 377 |
ASTHENIA |
81 |
0.0002 |
| 378 |
RENAL FUNCTION TEST ABNORMAL |
1 |
0.0002 |
| 379 |
SEASONAL ALLERGY |
3 |
0.0002 |
| 380 |
SKIN ABRASION |
1 |
0.0002 |
| 381 |
VOMITING |
98 |
0.0002 |
| 382 |
DIZZINESS POSTURAL |
2 |
0.0002 |
| 383 |
EAR PAIN |
4 |
0.0002 |
| 384 |
DYSPNOEA |
116 |
0.0002 |
| 385 |
COELIAC DISEASE |
2 |
0.0002 |
| 386 |
IMMUNODEFICIENCY |
3 |
0.0002 |
| 387 |
RESPIRATORY DISORDER |
6 |
0.0002 |
| 388 |
ABDOMINAL PAIN UPPER |
41 |
0.0002 |
| 389 |
CORONARY ARTERY STENOSIS |
1 |
0.0002 |
| 390 |
GASTROOESOPHAGEAL REFLUX DISEASE |
16 |
0.0002 |
| 391 |
DRUG TOLERANCE |
1 |
0.0002 |
| 392 |
PARAESTHESIA |
31 |
0.0002 |
| 393 |
URTICARIA |
33 |
0.0002 |
| 394 |
PERIPHERAL VASCULAR DISORDER |
1 |
0.0002 |
| 395 |
LIMB DISCOMFORT |
6 |
0.0002 |
| 396 |
POOR VENOUS ACCESS |
2 |
0.0002 |
| 397 |
CONFUSIONAL STATE |
31 |
0.0002 |
| 398 |
MEMORY IMPAIRMENT |
26 |
0.0002 |
| 399 |
COMPRESSION FRACTURE |
1 |
0.0002 |
| 400 |
ABDOMINAL DISCOMFORT |
31 |
0.0002 |
| 401 |
SKIN LACERATION |
2 |
0.0002 |
| 402 |
INTENTIONAL PRODUCT USE ISSUE |
16 |
0.0002 |
| 403 |
DEAFNESS UNILATERAL |
1 |
0.0002 |
| 404 |
ILL-DEFINED DISORDER |
11 |
0.0002 |
| 405 |
NAUSEA |
143 |
0.0002 |
| 406 |
INJECTION SITE INJURY |
1 |
0.0002 |
| 407 |
STREPTOCOCCAL INFECTION |
1 |
0.0002 |
| 408 |
NASOPHARYNGITIS |
33 |
0.0002 |
| 409 |
BLOOD CALCIUM DECREASED |
2 |
0.0002 |
| 410 |
HYPERSENSITIVITY |
33 |
0.0002 |
| 411 |
SKIN TOXICITY |
1 |
0.0002 |
| 412 |
CARDIAC VALVE DISEASE |
1 |
0.0002 |
| 413 |
MUSCLE SPASMS |
32 |
0.0002 |
| 414 |
PARANOIA |
3 |
0.0002 |
| 415 |
EXERCISE TOLERANCE DECREASED |
1 |
0.0002 |
| 416 |
PRODUCT USE IN UNAPPROVED INDICATION |
42 |
0.0002 |
| 417 |
SQUAMOUS CELL CARCINOMA OF SKIN |
1 |
0.0002 |
| 418 |
WEIGHT INCREASED |
37 |
0.0002 |
| 419 |
CONCOMITANT DISEASE AGGRAVATED |
1 |
0.0002 |
| 420 |
PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION |
1 |
0.0002 |
| 421 |
PYREXIA |
56 |
0.0002 |
| 422 |
SCOLIOSIS |
1 |
0.0002 |
| 423 |
SWELLING OF EYELID |
1 |
0.0002 |
| 424 |
HYPOCALCAEMIA |
3 |
0.0002 |
| 425 |
MIGRAINE |
15 |
0.0002 |
| 426 |
THERAPY NON-RESPONDER |
7 |
0.0002 |
| 427 |
INCOHERENT |
1 |
0.0002 |
| 428 |
APPLICATION SITE VESICLES |
1 |
0.0002 |
| 429 |
NODULE |
2 |
0.0002 |
| 430 |
HYPOGAMMAGLOBULINAEMIA |
1 |
0.0002 |
| 431 |
BEDRIDDEN |
2 |
0.0002 |
| 432 |
PULMONARY CONGESTION |
2 |
0.0002 |
| 433 |
PRODUCT FORMULATION ISSUE |
1 |
0.0002 |
| 434 |
CORONAVIRUS INFECTION |
1 |
0.0002 |
| 435 |
APPETITE DISORDER |
1 |
0.0002 |
| 436 |
ADVERSE REACTION |
2 |
0.0002 |
| 437 |
PREGNANCY |
3 |
0.0001 |
| 438 |
GENERAL PHYSICAL CONDITION ABNORMAL |
1 |
0.0001 |
| 439 |
IMPAIRED GASTRIC EMPTYING |
2 |
0.0001 |
| 440 |
EYE MOVEMENT DISORDER |
1 |
0.0001 |
| 441 |
TREATMENT FAILURE |
12 |
0.0001 |
| 442 |
HYPERTRANSAMINASAEMIA |
1 |
0.0001 |
| 443 |
RASH MACULAR |
5 |
0.0001 |
| 444 |
APPLICATION SITE REACTION |
1 |
0.0001 |
| 445 |
BACK PAIN |
33 |
0.0001 |
| 446 |
IMPAIRED QUALITY OF LIFE |
2 |
0.0001 |
| 447 |
MAJOR DEPRESSION |
1 |
0.0001 |
| 448 |
SINUSITIS |
14 |
0.0001 |
| 449 |
OFF LABEL USE |
119 |
0.0001 |
| 450 |
CEREBRAL DISORDER |
1 |
0.0001 |
| 451 |
MATERNAL EXPOSURE DURING PREGNANCY |
12 |
0.0001 |
| 452 |
ECONOMIC PROBLEM |
2 |
0.0001 |
| 453 |
INSURANCE ISSUE |
2 |
0.0001 |
| 454 |
DEVICE PHYSICAL PROPERTY ISSUE |
1 |
0.0001 |
| 455 |
BRONCHOPULMONARY ASPERGILLOSIS |
1 |
0.0001 |
| 456 |
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS |
1 |
0.0001 |
| 457 |
HYPOALBUMINAEMIA |
1 |
0.0001 |
| 458 |
MULTIPLE ALLERGIES |
1 |
0.0001 |
| 459 |
FATIGUE |
97 |
0.0001 |
| 460 |
RHINITIS |
1 |
0.0001 |
| 461 |
STENT PLACEMENT |
1 |
0.0001 |
| 462 |
POST PROCEDURAL INFECTION |
1 |
0.0001 |
| 463 |
ADVERSE DRUG REACTION |
11 |
0.0001 |
| 464 |
MANIA |
2 |
0.0001 |
| 465 |
ACUTE CORONARY SYNDROME |
1 |
0.0001 |
| 466 |
EOSINOPHIL COUNT INCREASED |
1 |
0.0001 |
| 467 |
INFUSION SITE ERYTHEMA |
1 |
0.0001 |
| 468 |
HEPATITIS |
3 |
0.0001 |
| 469 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
21 |
0.0001 |
| 470 |
MUSCULAR WEAKNESS |
13 |
0.0001 |
| 471 |
MALAISE |
50 |
0.0001 |
| 472 |
PRODUCT COMMUNICATION ISSUE |
1 |
0.0001 |
| 473 |
DRUG ERUPTION |
2 |
0.0001 |
| 474 |
PNEUMONIA |
36 |
0.0001 |
| 475 |
LOSS OF LIBIDO |
1 |
0.0001 |
| 476 |
FREQUENT BOWEL MOVEMENTS |
3 |
0.0001 |
| 477 |
GASTROENTERITIS VIRAL |
2 |
0.0001 |
| 478 |
SKIN LESION |
3 |
0.0001 |
| 479 |
BLOOD THYROID STIMULATING HORMONE INCREASED |
1 |
0.0001 |
| 480 |
TREMOR |
18 |
0.0001 |
| 481 |
INTERVERTEBRAL DISC DEGENERATION |
1 |
0.0001 |
| 482 |
NECK PAIN |
6 |
0.0001 |
| 483 |
EYE PAIN |
6 |
0.0001 |
| 484 |
DYSPNOEA EXERTIONAL |
4 |
0.0001 |
| 485 |
BLOOD SODIUM DECREASED |
2 |
0.0001 |
| 486 |
SPINAL DISORDER |
1 |
0.0001 |
| 487 |
FALL |
35 |
0.0001 |
| 488 |
RECALLED PRODUCT ADMINISTERED |
1 |
0.0001 |
| 489 |
PRODUCTIVE COUGH |
5 |
0.0001 |
| 490 |
ATELECTASIS |
1 |
0.0001 |
| 491 |
BLOOD PRESSURE SYSTOLIC INCREASED |
2 |
0.0001 |
| 492 |
CHOKING |
2 |
0.0001 |
| 493 |
VITREOUS FLOATERS |
1 |
0.0001 |
| 494 |
BLADDER DISORDER |
1 |
0.0001 |
| 495 |
BLOOD PRESSURE ABNORMAL |
2 |
0.0001 |
| 496 |
SALIVARY HYPERSECRETION |
1 |
0.0001 |
| 497 |
BRAIN INJURY |
1 |
0.0001 |
| 498 |
HYPOTHERMIA |
1 |
0.0001 |
| 499 |
TOOTH ABSCESS |
1 |
0.0001 |
| 500 |
BODY TEMPERATURE INCREASED |
2 |
0.0001 |
| 501 |
ADVERSE EVENT |
9 |
0.0001 |
| 502 |
TEMPERATURE INTOLERANCE |
1 |
0.0001 |
| 503 |
EYE DISCHARGE |
1 |
0.0001 |
| 504 |
TENDERNESS |
1 |
0.0001 |
| 505 |
PRODUCT QUALITY ISSUE |
13 |
0.0001 |
| 506 |
WEIGHT FLUCTUATION |
1 |
0.0001 |
| 507 |
TRANSFUSION |
1 |
0.0001 |
| 508 |
PRODUCT DOSE OMISSION ISSUE |
28 |
0.0001 |
| 509 |
INJECTION SITE DISCOMFORT |
1 |
0.0001 |
| 510 |
SUDDEN DEATH |
1 |
0.0001 |
| 511 |
PAIN |
58 |
0.0001 |
| 512 |
OESOPHAGITIS |
1 |
0.0001 |
| 513 |
INTERVERTEBRAL DISC PROTRUSION |
2 |
0.0001 |
| 514 |
BLOOD GLUCOSE FLUCTUATION |
1 |
0.0001 |
| 515 |
COLITIS ULCERATIVE |
4 |
0.0001 |
| 516 |
SKIN INFECTION |
1 |
0.0001 |
| 517 |
OCULAR DISCOMFORT |
1 |
0.0001 |
| 518 |
APPLICATION SITE PRURITUS |
2 |
0.0001 |
| 519 |
SCAB |
1 |
0.0001 |
| 520 |
HAEMATURIA |
3 |
0.0001 |
| 521 |
NEOPLASM |
1 |
0.0001 |
| 522 |
HYPOKALAEMIA |
4 |
0.0001 |
| 523 |
SEXUAL DYSFUNCTION |
1 |
0.0001 |
| 524 |
COVID-19 PNEUMONIA |
1 |
0.0001 |
| 525 |
OCULAR HYPERAEMIA |
4 |
0.0001 |
| 526 |
BLOOD IRON DECREASED |
1 |
0.0001 |
| 527 |
MACULAR DEGENERATION |
1 |
0.0001 |
| 528 |
BLOOD PRESSURE FLUCTUATION |
2 |
0.0001 |
| 529 |
RESPIRATORY DEPRESSION |
1 |
0.0001 |
| 530 |
MUSCLE SPASTICITY |
1 |
0.0001 |
| 531 |
GLOMERULAR FILTRATION RATE DECREASED |
1 |
0.0001 |
| 532 |
GENERALISED OEDEMA |
1 |
0.0001 |
| 533 |
RASH |
35 |
0.0001 |
| 534 |
DIZZINESS |
40 |
0.0001 |
| 535 |
WEIGHT DECREASED |
22 |
0.0001 |
| 536 |
TACHYCARDIA |
7 |
0.0001 |
| 537 |
DRUG INEFFECTIVE |
103 |
0.0001 |
| 538 |
ERECTILE DYSFUNCTION |
2 |
0.0001 |
| 539 |
DIPLOPIA |
2 |
0.0001 |
| 540 |
TOOTH INFECTION |
1 |
0.0001 |
| 541 |
QUALITY OF LIFE DECREASED |
1 |
0.0001 |
| 542 |
PROCEDURAL PAIN |
2 |
0.0001 |
| 543 |
HUNGER |
1 |
0.0001 |
| 544 |
HEADACHE |
45 |
0.0001 |
| 545 |
DEMENTIA |
2 |
0.0001 |
| 546 |
CARPAL TUNNEL SYNDROME |
1 |
0.0001 |
| 547 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
5 |
0.0001 |
| 548 |
SUBDURAL HAEMATOMA |
1 |
0.0001 |
| 549 |
HYPERSOMNIA |
2 |
0.0001 |
| 550 |
LETHARGY |
4 |
0.0001 |
| 551 |
EYE IRRITATION |
4 |
0.0001 |
| 552 |
PARAESTHESIA ORAL |
1 |
0.0001 |
| 553 |
MYELODYSPLASTIC SYNDROME |
1 |
0.0001 |
| 554 |
SEPTIC SHOCK |
3 |
0.0001 |
| 555 |
COMPLICATION ASSOCIATED WITH DEVICE |
1 |
0.0001 |
| 556 |
NASAL CONGESTION |
4 |
0.0001 |
| 557 |
PSYCHOTIC DISORDER |
2 |
0.0001 |
| 558 |
BRONCHITIS |
5 |
0.0001 |
| 559 |
HYPOAESTHESIA ORAL |
1 |
0.0001 |
| 560 |
LACRIMATION INCREASED |
2 |
0.0001 |
| 561 |
DIARRHOEA |
42 |
0.0001 |
| 562 |
ANKLE FRACTURE |
1 |
0.0001 |
| 563 |
PAIN IN EXTREMITY |
19 |
0.0001 |
| 564 |
EXPOSURE DURING PREGNANCY |
4 |
0.0001 |
| 565 |
EJECTION FRACTION DECREASED |
1 |
0.0001 |
| 566 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
1 |
0.0001 |
| 567 |
PNEUMOTHORAX |
1 |
0.0001 |
| 568 |
ABSCESS |
1 |
0.0001 |
| 569 |
SYNCOPE |
6 |
0.0001 |
| 570 |
AGGRESSION |
3 |
0.0001 |
| 571 |
URINARY RETENTION |
2 |
0.0001 |
| 572 |
BLOOD UREA INCREASED |
1 |
0.0001 |
| 573 |
CELLULITIS |
3 |
0.0001 |
| 574 |
ORTHOSTATIC HYPOTENSION |
1 |
0.0001 |
| 575 |
DEVICE USE ISSUE |
1 |
0.0001 |
| 576 |
COUGH |
16 |
0.0001 |
| 577 |
COLD SWEAT |
1 |
0.0001 |
| 578 |
VISUAL IMPAIRMENT |
7 |
0.0001 |
| 579 |
HEAD DISCOMFORT |
1 |
0.0001 |
| 580 |
TREATMENT NONCOMPLIANCE |
3 |
0.0001 |
| 581 |
ACCIDENTAL OVERDOSE |
2 |
0.0001 |
| 582 |
LOSS OF CONSCIOUSNESS |
7 |
0.0001 |
| 583 |
BLOOD GLUCOSE ABNORMAL |
1 |
0.0001 |
| 584 |
MEDICATION ERROR |
3 |
0.0001 |
| 585 |
THINKING ABNORMAL |
1 |
0.0001 |
| 586 |
DEATH |
46 |
0.0001 |
| 587 |
PHOTOPHOBIA |
1 |
0.0001 |
| 588 |
PROTEINURIA |
1 |
0.0001 |
| 589 |
INCREASED APPETITE |
1 |
0.0001 |
| 590 |
SEROTONIN SYNDROME |
1 |
0.0001 |
| 591 |
SEIZURE |
6 |
0.0001 |
| 592 |
BONE PAIN |
3 |
0.0001 |
| 593 |
KIDNEY INFECTION |
1 |
0.0001 |
| 594 |
SINUS DISORDER |
1 |
0.0001 |
| 595 |
UPPER LIMB FRACTURE |
1 |
0.0001 |
| 596 |
PRURITUS |
19 |
0.0000 |
| 597 |
NEUTROPHIL COUNT DECREASED |
2 |
0.0000 |
| 598 |
FEELING HOT |
3 |
0.0000 |
| 599 |
EATING DISORDER |
1 |
0.0000 |
| 600 |
IMPAIRED WORK ABILITY |
1 |
0.0000 |
| 601 |
RECTAL HAEMORRHAGE |
2 |
0.0000 |
| 602 |
POOR QUALITY SLEEP |
1 |
0.0000 |
| 603 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
1 |
0.0000 |
| 604 |
ALTERED STATE OF CONSCIOUSNESS |
1 |
0.0000 |
| 605 |
BLOOD PRESSURE INCREASED |
7 |
0.0000 |
| 606 |
APPLICATION SITE PAIN |
1 |
0.0000 |
| 607 |
CHROMATURIA |
1 |
0.0000 |
| 608 |
HEART RATE IRREGULAR |
1 |
0.0000 |
| 609 |
VISION BLURRED |
6 |
0.0000 |
| 610 |
MUSCLE TWITCHING |
1 |
0.0000 |
| 611 |
OROPHARYNGEAL PAIN |
4 |
0.0000 |
| 612 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
1 |
0.0000 |
| 613 |
CARDIAC DISORDER |
4 |
0.0000 |
| 614 |
DISEASE PROGRESSION |
5 |
0.0000 |
| 615 |
ARRHYTHMIA |
2 |
0.0000 |
| 616 |
THERAPY INTERRUPTED |
3 |
0.0000 |
| 617 |
PRESYNCOPE |
1 |
0.0000 |
| 618 |
UNDERDOSE |
3 |
0.0000 |
| 619 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
1 |
0.0000 |
| 620 |
DRY EYE |
2 |
0.0000 |
| 621 |
DEPRESSION |
9 |
0.0000 |
| 622 |
ABDOMINAL PAIN LOWER |
1 |
0.0000 |
| 623 |
HYPOPHAGIA |
1 |
0.0000 |
| 624 |
ILLNESS |
4 |
0.0000 |
| 625 |
HYPERHIDROSIS |
5 |
0.0000 |
| 626 |
SKIN ULCER |
1 |
0.0000 |
| 627 |
ANXIETY |
11 |
0.0000 |
| 628 |
DEAFNESS |
1 |
0.0000 |
| 629 |
SEDATION |
1 |
0.0000 |
| 630 |
APPLICATION SITE ERYTHEMA |
1 |
0.0000 |
| 631 |
ANHEDONIA |
1 |
0.0000 |
| 632 |
DEPRESSED MOOD |
2 |
0.0000 |
| 633 |
BRADYCARDIA |
2 |
0.0000 |
| 634 |
INJECTION SITE BRUISING |
3 |
0.0000 |
| 635 |
INSOMNIA |
10 |
0.0000 |
| 636 |
BLOOD BILIRUBIN INCREASED |
1 |
0.0000 |
| 637 |
RASH PRURITIC |
2 |
0.0000 |
| 638 |
RESPIRATORY ARREST |
1 |
0.0000 |
| 639 |
RESPIRATORY DISTRESS |
1 |
0.0000 |
| 640 |
DIVERTICULITIS |
1 |
0.0000 |
| 641 |
INFLUENZA |
4 |
0.0000 |
| 642 |
OXYGEN SATURATION DECREASED |
2 |
0.0000 |
| 643 |
INTENTIONAL DOSE OMISSION |
1 |
0.0000 |
| 644 |
RED BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 645 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
1 |
0.0000 |
| 646 |
LABORATORY TEST ABNORMAL |
1 |
0.0000 |
| 647 |
FEELING ABNORMAL |
8 |
0.0000 |
| 648 |
APHASIA |
1 |
0.0000 |
| 649 |
THERAPEUTIC RESPONSE DECREASED |
2 |
0.0000 |
| 650 |
VERTIGO |
2 |
0.0000 |
| 651 |
FEMUR FRACTURE |
1 |
0.0000 |
| 652 |
NERVOUS SYSTEM DISORDER |
1 |
0.0000 |
| 653 |
SWOLLEN TONGUE |
1 |
0.0000 |
| 654 |
DYSPHAGIA |
3 |
0.0000 |
| 655 |
METABOLIC ACIDOSIS |
1 |
0.0000 |
| 656 |
HIP FRACTURE |
1 |
0.0000 |
| 657 |
THERAPEUTIC RESPONSE SHORTENED |
1 |
0.0000 |
| 658 |
FEBRILE NEUTROPENIA |
2 |
0.0000 |
| 659 |
FUNGAL INFECTION |
1 |
0.0000 |
| 660 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
1 |
0.0000 |
| 661 |
CHEST DISCOMFORT |
3 |
0.0000 |
| 662 |
GASTRIC DISORDER |
1 |
0.0000 |
| 663 |
INJECTION SITE REACTION |
2 |
0.0000 |
| 664 |
HYPERKALAEMIA |
1 |
0.0000 |
| 665 |
LYMPHADENOPATHY |
1 |
0.0000 |
| 666 |
PLATELET COUNT DECREASED |
3 |
0.0000 |
| 667 |
PRODUCT ADHESION ISSUE |
1 |
0.0000 |
| 668 |
CEREBRAL HAEMORRHAGE |
1 |
0.0000 |
| 669 |
CRYING |
1 |
0.0000 |
| 670 |
HYPERGLYCAEMIA |
1 |
0.0000 |
| 671 |
PANIC ATTACK |
1 |
0.0000 |
| 672 |
EYE SWELLING |
1 |
0.0000 |
| 673 |
HEPATIC FUNCTION ABNORMAL |
1 |
0.0000 |
| 674 |
DYSARTHRIA |
1 |
0.0000 |
| 675 |
HOT FLUSH |
2 |
0.0000 |
| 676 |
CHRONIC KIDNEY DISEASE |
2 |
0.0000 |
| 677 |
WHITE BLOOD CELL COUNT INCREASED |
1 |
0.0000 |
| 678 |
PLASMA CELL MYELOMA |
1 |
0.0000 |
| 679 |
CHILLS |
3 |
0.0000 |
| 680 |
DISORIENTATION |
1 |
0.0000 |
| 681 |
DRUG INTERACTION |
4 |
0.0000 |
| 682 |
CARDIAC FAILURE |
2 |
0.0000 |
| 683 |
DEVICE BREAKAGE |
1 |
0.0000 |
| 684 |
RHABDOMYOLYSIS |
1 |
0.0000 |
| 685 |
WITHDRAWAL SYNDROME |
1 |
0.0000 |
| 686 |
RENAL IMPAIRMENT |
2 |
0.0000 |
| 687 |
MYALGIA |
4 |
0.0000 |
| 688 |
HYPOACUSIS |
1 |
0.0000 |
| 689 |
DEVICE LEAKAGE |
1 |
0.0000 |
| 690 |
MENTAL DISORDER |
1 |
0.0000 |
| 691 |
DRY SKIN |
3 |
0.0000 |
| 692 |
PULMONARY OEDEMA |
1 |
0.0000 |
| 693 |
THERAPEUTIC RESPONSE UNEXPECTED |
1 |
0.0000 |
| 694 |
THROAT IRRITATION |
1 |
0.0000 |
| 695 |
NEUTROPENIA |
3 |
0.0000 |
| 696 |
NEPHROLITHIASIS |
1 |
0.0000 |
| 697 |
TINNITUS |
1 |
0.0000 |
| 698 |
BREAST CANCER |
2 |
0.0000 |
| 699 |
COGNITIVE DISORDER |
1 |
0.0000 |
| 700 |
HEART RATE INCREASED |
2 |
0.0000 |
| 701 |
LEUKOPENIA |
1 |
0.0000 |
| 702 |
HYPOTENSION |
4 |
0.0000 |
| 703 |
ACUTE KIDNEY INJURY |
3 |
0.0000 |
| 704 |
HOSPITALISATION |
3 |
0.0000 |
| 705 |
HAEMOGLOBIN DECREASED |
2 |
0.0000 |
| 706 |
SPEECH DISORDER |
1 |
0.0000 |
| 707 |
PANCREATITIS |
1 |
0.0000 |
| 708 |
DISTURBANCE IN ATTENTION |
1 |
0.0000 |
| 709 |
WHITE BLOOD CELL COUNT DECREASED |
2 |
0.0000 |
| 710 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 711 |
HAEMATOCHEZIA |
1 |
0.0000 |
| 712 |
FLATULENCE |
1 |
0.0000 |
| 713 |
URINARY TRACT INFECTION |
3 |
0.0000 |
| 714 |
PALPITATIONS |
2 |
0.0000 |
| 715 |
EMOTIONAL DISTRESS |
2 |
0.0000 |
| 716 |
SUICIDE ATTEMPT |
1 |
0.0000 |
| 717 |
ALANINE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 718 |
BLOOD GLUCOSE INCREASED |
3 |
0.0000 |
| 719 |
SWELLING FACE |
1 |
0.0000 |
| 720 |
DEHYDRATION |
2 |
0.0000 |
| 721 |
NEOPLASM MALIGNANT |
1 |
0.0000 |
| 722 |
SKIN BURNING SENSATION |
1 |
0.0000 |
| 723 |
OVERDOSE |
3 |
0.0000 |
| 724 |
EPISTAXIS |
1 |
0.0000 |
| 725 |
HALLUCINATION |
1 |
0.0000 |
| 726 |
UNEVALUABLE EVENT |
1 |
0.0000 |
| 727 |
INJECTION SITE HAEMORRHAGE |
1 |
0.0000 |
| 728 |
CARDIAC FAILURE CONGESTIVE |
1 |
0.0000 |
| 729 |
GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0000 |
| 730 |
TOXICITY TO VARIOUS AGENTS |
2 |
0.0000 |
| 731 |
SKIN EXFOLIATION |
1 |
0.0000 |
| 732 |
BALANCE DISORDER |
1 |
0.0000 |
| 733 |
MYOCARDIAL INFARCTION |
2 |
0.0000 |
| 734 |
COVID-19 |
2 |
0.0000 |
| 735 |
DEVICE ISSUE |
1 |
0.0000 |
| 736 |
NEUROPATHY PERIPHERAL |
1 |
0.0000 |
| 737 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
2 |
0.0000 |
| 738 |
ERYTHEMA |
2 |
0.0000 |
| 739 |
THROMBOCYTOPENIA |
1 |
0.0000 |
| 740 |
INCORRECT DOSE ADMINISTERED |
2 |
0.0000 |
| 741 |
INJECTION SITE PAIN |
2 |
0.0000 |
| 742 |
NO ADVERSE EVENT |
1 |
0.0000 |